News Detail
Jun 22, 2018
Pharmasum Therapeutics featured in the Norwegian Biotechnology Association publication

"Pharmasum is gearing up to enter clinical studies in Down syndrome.

We are trying to dramatically improve the lives of individuals with Down syndrome, by improving cognition and possibly slowing down Alzheimer's pathology."

Click here to view publication